# Gemini Enterprise Molecule Lifecycle

This reference describes the end-to-end journey of a molecule through Gemini Enterprise, covering discovery, research, clinical, regulatory, and commercial phases.

## 1. Discovery
A researcher collaborates with Gemini to architect a novel in-silico experimental design for the discovery of a CDK4 inhibitor. Utilizing the Co-Scientist Agent, the platform orchestrates a frictionless synthesis of proprietary internal reports and external literature via OneMCP to propose a high-fidelity program. Gemini then serves as the cognitive partner, assisting the researcher in executing the discovery workflow to accelerate the trajectory toward successful candidate identification.

## 2. Research and Preclinical
The user highlights the candidate and prompts Gemini Enterprise to run a simulation. Gemini routes the request to AlphaFold 2 (for SBDD docking) and AlphaGenome (for variant impact), followed by TxGemma for ADMET profiling, ensuring that the dosage used in animal models is more likely to mirror expected human outcomes. The platform then utilizes Nano-Banana-Pro capabilities to automatically generate a publication-ready pathway diagram.

## 3. Clinical Design
The Co-Scientist Agent can enhance Clinical Trial design by providing advanced patient stratification, synthetic control arms, suggest appropriate Estimands, and dose escalation modeling. It can also “stress test” the suggested design and schedule of activities checking dosing schedules and endpoints.

## 4. Clinical Operations
Gemini in BigQuery can to constantly scan clinical data to strive for the “Zero-Query Trials”, using semantic QC, auto-drafting queries, and predictive data lock, shaving several months off clinical trials. Gemini goes beyond basic threshold alerts to understand medical context. For example, if a patient is on a blood thinner but their lab results show no change in coagulation markers, Gemini can flag this "medical logic" gap instantly. Gemini’s unique strength in multimodal capabilities can provide QC reconciliation across clinical data, labs and imaging.

## 5. Regulatory Operations
NotebookLM can be used to instantly draft CMC summaries, Clinical Study Reports, and other submission related documents in the appropriate format, pulling from related documents without advanced prompt engineering.

## 6. Regulatory Intelligence
Preempt health authority queries and rectify submission inconsistencies, eliminating costly review delays, CRLs, and other agency questions. Revolutionize query responses by integrating Gemini Enterprise with Veeva and email. Securely automate triage and drafting to rapidly link disparate data while protecting IP.

## 7. Medical Engagement
Using Gemini Enterprise for Customer Experience, patients and health care providers will be met with highly personalized, dynamic responses to Medical Queries on the drug, administration, side effects, etc. while providing insights tailored to the questions but ensuring diagnostic guardrails.

## 8. Commercial Reach
AI generated videos for advertisements and promotional material can be dynamically created globally at scale, using Gemini Creative Media Studio. Agents will dynamically incorporate approved content and claims, and provide continuous Medical and Legal reviews, to reap the benefits of AI while ensuring quality and compliance.
